Repligen (RGEN) Capital Expenditures (2010 - 2026)

Repligen (RGEN) has 17 years of Capital Expenditures data on file, last reported at $4.7 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $4.7 million, up 443.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.4 million (up 3.19% YoY), and the FY2025 annual result was $23.5 million, down 8.4% from the prior year.
• Capital Expenditures fell to $4.7 million in Q1 2026 per RGEN's latest filing, from $21.5 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $82.3 million in Q4 2022 and troughed at -$50.0 million in Q3 2022.
• A 5-year average of $10.3 million and a median of $4.7 million in 2026 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures tumbled 6732.36% in 2022, then surged 3111.11% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $82.3 million in 2022, then plunged by 59.3% to $33.5 million in 2023, then slumped by 83.46% to $5.5 million in 2024, then jumped by 287.44% to $21.5 million in 2025, then tumbled by 78.06% to $4.7 million in 2026.
• Business Quant data shows RGEN's Capital Expenditures at $4.7 million in Q1 2026, $21.5 million in Q4 2025, and -$8.6 million in Q3 2025.